US Parkinson’s Disease Drug Pipeline Analysis:Life Sciences Market Research Reports

Life Sciences Market Research Reports

LSAT prep from HLS-educated instructors LSATMax includes video lessons, unlimited personal attention & support, and over 6,000 real questions from previous LSAT's. Enroll for just $299. From our sponsors

US Parkinson's Disease Drug Pipeline Analysis Nov 18th 2013, 00:00, by vyankatesh Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds USD 20 billion annually. The risk of this disease increases with age, thus implying that as the population in the US gets older, the impact of this disease on the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131055. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/us-parkinsons-disease-drug-pipeline-analysis-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions